{'fraction_non_alphanumeric': 0.01968503937007874, 'fraction_numerical': 0.00984251968503937, 'mean_word_length': 6.069444444444445, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Sex‐differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: The Casale Monferrato Study

Aims  Although left ventricular hypertrophy (LVH) defined by either standard 12‐lead ECG or echocardiography strongly predicts cardiovascular mortality, its prevalence in Type 2 diabetes is largely unknown. We have assessed prevalence of ECG‐LVH and its relationship with clinical and metabolic variables in an Italian population‐based cohort of subjects with Type 2 diabetes.